Literature DB >> 9358207

Testosterone sulphation and glucuronidation in the human liver: interindividual variability.

G M Pacifici1, A Gucci, L Giuliani.   

Abstract

Presystemic sulphation and glucuronidation at OH-C17 limits the bioavailability of testosterone; the aim of this investigation was to describe the variability in testosterone sulphation and glucuronidation rates in the human liver. Liver samples were obtained from 61 women and 40 men of similar age (mean 53 and 55 years, respectively) submitted to surgery. The mean rate of testosterone sulphation was significantly (P = 0.002) higher in men (22.4 pmol/min/mg) than in women (17.5 pmol/min/mg), was not age-dependent, followed bimodal distribution and varied over 7-fold in men and women. There was a weak, but significant negative correlation (r = -0.380; P = 0.003), between the rate of testosterone glucuronidation and age in the liver of women but not in that of men. The mean rate (pmol/min/mg) of testosterone glucuronidation was 155 (men) and 105 (women) (NS) and varied over 20-fold. When the rate of testosterone glucuronidation was expressed on the basis of g liver equivalent, the mean estimates were significantly (P = 0.003) greater in men (3323 pmol/min/g) than in women (1841 pmol/min/g). The present findings are consistent with the view that the hepatic activities of sulphotransferase and glucuronosyltransferase are higher in men than in women and that they vary in the human liver.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9358207     DOI: 10.1007/BF03189815

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  19 in total

1.  Differential distribution of phenol and catechol sulphotransferases in human liver and intestinal mucosa.

Authors:  M Cappiello; L Giuliani; G M Pacifici
Journal:  Pharmacology       Date:  1990       Impact factor: 2.547

2.  The influence of environmental and genetic factors on CYP2D6, CYP1A2 and UDP-glucuronosyltransferases in man using sparteine, caffeine, and paracetamol as probes.

Authors:  K W Bock; D Schrenk; A Forster; E U Griese; K Mörike; D Brockmeier; M Eichelbaum
Journal:  Pharmacogenetics       Date:  1994-08

Review 3.  Specificity of human UDP-glucuronosyltransferases and xenobiotic glucuronidation.

Authors:  B Burchell; C H Brierley; D Rance
Journal:  Life Sci       Date:  1995       Impact factor: 5.037

4.  An improved assay for steroid glucuronyltransferase in rat liver microsomes.

Authors:  G S Rao; G Haueter; M L Rao; H Breuer
Journal:  Anal Biochem       Date:  1976-07       Impact factor: 3.365

5.  Interindividual and interethnic differences in the demethylation and glucuronidation of codeine.

Authors:  Q Y Yue; J O Svensson; C Alm; F Sjöqvist; J Säwe
Journal:  Br J Clin Pharmacol       Date:  1989-12       Impact factor: 4.335

6.  Zidovudine glucuronidation in human liver: interindividual variability.

Authors:  G M Pacifici; L Evangelisti; L Giuliani; R M Metelli; R Giordani
Journal:  Int J Clin Pharmacol Ther       Date:  1996-08       Impact factor: 1.366

7.  Minoxidil sulphation in human liver and platelets. A study of interindividual variability.

Authors:  G M Pacifici; R Bigotti; G Marchi; L Giuliani
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

8.  Interindividual variability in the glucuronidation of (S) oxazepam contrasted with that of (R) oxazepam.

Authors:  M Patel; B K Tang; D M Grant; W Kalow
Journal:  Pharmacogenetics       Date:  1995-10

9.  Interindividual variability in the glucuronidation and sulphation of ethinyloestradiol in human liver.

Authors:  A Temellini; L Giuliani; G M Pacifici
Journal:  Br J Clin Pharmacol       Date:  1991-06       Impact factor: 4.335

10.  Human liver budesonide sulphotransferase is inhibited by testosterone and correlates with by testosterone sulphotransferase.

Authors:  G M Pacifici; M A Ferroni; A Temellini; A Gucci; M C Morelli; L Giuliani
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953

View more
  2 in total

1.  Differential sensitivities of bladder cancer cell lines to resveratol are unrelated to its metabolic profile.

Authors:  Yang Yang; Chuangang Li; Hong Li; Moli Wu; Changle Ren; Yuhong Zhen; Xiaochi Ma; Yunpeng Diao; Xiaodong Ma; Sa Deng; Jia Liu; Xiaohong Shu
Journal:  Oncotarget       Date:  2017-06-20

2.  An oral lipidic native testosterone formulation that is absorbed independent of food.

Authors:  John Newell-Price; Hiep Huatan; Jo Quirke; John Porter; Eleni Daniel; Enis Mumdzic; Bernard Voet; Brian Keevil; Martin J Whitaker; Richard J Ross
Journal:  Eur J Endocrinol       Date:  2021-10-05       Impact factor: 6.664

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.